OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
By: OncoBeta GmbH MUNICH – OncoBeta® GmbH, a medical device company specialising in innovative epidermal radioisotope therapies, has announced 12-months interim results from its international Phase IV, multi-centre clinical trial…
